BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/21/2021 8:56:15 AM | Browse: 455 | Download: 787
 |
Received |
|
2021-03-29 18:39 |
|
Peer-Review Started |
|
2021-03-29 18:42 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-25 10:53 |
|
Revised |
|
2021-07-08 09:10 |
|
Second Decision |
|
2021-09-09 03:22 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-09-10 09:27 |
|
Articles in Press |
|
2021-09-10 09:27 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-10-20 05:05 |
|
Publish the Manuscript Online |
|
2021-10-21 08:56 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors: A meta-analysis of cardiovascular outcome trials
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Dimitrios Ioannis Patoulias, Aristi Boulmpou, Eleftherios Teperikidis, Alexandra Katsimardou, Fotios Siskos, Michael Doumas, Christodoulos E Papadopoulos and Vassilios Vassilikos |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dimitrios Ioannis Patoulias, MD, MSc, Doctor, Doctor, Research Fellow, Research Scientist, Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, Konstantinoupoleos 49 Str., Thessaloniki 54642, Greece. dipatoulias@gmail.com |
| Key Words |
Dipeptidyl peptidase-4 inhibitors; Cardiovascular outcomes; Atrial fibrillation; Atrial flutter; Type 2 diabetes mellitus |
| Core Tip |
The antidiabetic efficacy of dipeptidyl peptidase-4 (DPP-4) inhibitors has already been proven in recently published large randomized controlled trials. The purpose of the present meta-analysis was to clarify the impact of antidiabetic therapy with DPP-4 inhibitors on surrogate cardiovascular outcomes, and to elucidate the effect of these drugs on major cardiac arrhythmias. According to our analysis, this drug class does not significantly affect the risk for any of the addressed cardiovascular outcomes; however, it increases the risk for atrial flutter compared to placebo. |
| Publish Date |
2021-10-21 08:56 |
| Citation |
Patoulias DI, Boulmpou A, Teperikidis E, Katsimardou A, Siskos F, Doumas M, Papadopoulos CE, Vassilikos V. Cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors: A meta-analysis of cardiovascular outcome trials. World J Cardiol 2021; 13(10): 585-592 |
| URL |
https://www.wjgnet.com/1949-8462/full/v13/i10/585.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v13.i10.585 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
